Royal Society of Medicine-autosomal dominant polycystic kidney disease - clinical management and new therapies

Website link

www.rsm.ac.uk/events/events-listing/2015-2016/sections/nephrology-section/neg02-autosomal-dominant-polycystic-kidney-disease-clinical-management-and-new-therapies.aspx

Event location

Royal Society of Medicine, London

Contact details

Verity Cotton

Tel: 02072903947

Fax: 02072902989

Email: nephrology@rsm.ac.uk

Comments

This one day conference will update you on key developments in autosomal dominant polycystic kidney disease (ADPKD) through the review of clinical trials, novel therapies and disease progression tools. The meeting will look at ADPKD through the perspectives of different specialists, as well as review of the WGIKD summary, the TEMPO 3:4 Trial and who to treat with the Jinarc drug, which was recently recommended by NICE. The conference will include keynote lectures by Professor Yannick Le Meur from the Universite de Bretagne Occidentale, France, Professor Gerd Walz from the University Medical Centre Freiburg, Germany and Professor Olivier Devuyst from the University of Zurich, Switzerland. At the end of the meeting, attendees will have a better understanding of: The clinical overview of ADPKD How to monitor disease progression Recent reviews of clinical trials and novel therapies An overview of management and treatment for ADPKD The conference is most suitable for nephrologists, paediatricians, geneticists, nurses, members of the multi-disciplinary management team, scientists and patients, however all disciplines are welcome.

Submit an event